European Commission

News

The EU has approved UCB's Kygevvi for rare disease TK2d, and Sanofi's acute GvHD therapy Rezurock, in a pair of decisions announced this morning.

News

Agreement has been reached on the reform of EU pharma legislation, but industry thinks it does not go far enough to restore the bloc's global status.

News

Sanofi has confirmed it is being investigated by the European Commission for potentially anticompetitive activity in its vaccines business.

News

Details have been published of the trade agreement between the US and EU, with confirmation of the tariff rates for pharmaceuticals.

News

Merck unit SpringWorks has claimed EU approval for Ogsiveo, becoming the first approved therapy for desmoid tumours in Europe.

News

After some initial confusion, it has been confirmed that the 15% tariff rate on US imports from the EU will extend to pharmaceuticals.